Dr. Daniel Rivas, MD

NPI: 1811209562
Total Payments
$36,213
2024 Payments
$9,715
Companies
2
Transactions
47

Payment Breakdown by Category

Other$36,072 (99.6%)
Food & Beverage$141.19 (0.4%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for serving as faculty or as a speaker for a medical education program $35,072 44 96.8%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,000 1 2.8%
Food and Beverage $141.19 2 0.4%

Top Paying Companies

Company Total Records Latest Year
Organon Llc $35,213 46 $0 (2024)
Merck Sharp & Dohme Corporation $1,000 1 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $9,715 11 Organon Llc ($9,715)
2023 $13,844 15 Organon LLC ($13,844)
2022 $11,654 20 Organon LLC ($11,654)
2019 $1,000 1 Merck Sharp & Dohme Corporation ($1,000)

All Payment Transactions

47 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
12/10/2024 Organon Llc NEXPLANON (Drug) Compensation for serving as faculty or as a speaker for a medical education program Cash or cash equivalent $2.01 General
Category: ETONOGESTREL
11/07/2024 Organon Llc Compensation for serving as faculty or as a speaker for a medical education program Cash or cash equivalent $41.54 General
11/07/2024 Organon Llc NEXPLANON (Drug) Compensation for serving as faculty or as a speaker for a medical education program Cash or cash equivalent $41.54 General
Category: ETONOGESTREL
11/04/2024 Organon Llc Compensation for serving as faculty or as a speaker for a medical education program Cash or cash equivalent $1,375.00 General
11/04/2024 Organon Llc NEXPLANON (Drug) Compensation for serving as faculty or as a speaker for a medical education program Cash or cash equivalent $1,375.00 General
Category: ETONOGESTREL
10/21/2024 Organon Llc NEXPLANON (Drug) Compensation for serving as faculty or as a speaker for a medical education program Cash or cash equivalent $1,375.00 General
Category: ETONOGESTREL
08/12/2024 Organon Llc NEXPLANON (Drug) Compensation for serving as faculty or as a speaker for a medical education program Cash or cash equivalent $1,375.00 General
Category: ETONOGESTREL
06/20/2024 Organon Llc NEXPLANON (Drug) Compensation for serving as faculty or as a speaker for a medical education program Cash or cash equivalent $1,375.00 General
Category: ETONOGESTREL
04/08/2024 Organon Llc NEXPLANON (Drug) Compensation for serving as faculty or as a speaker for a medical education program Cash or cash equivalent $1,375.00 General
Category: ETONOGESTREL
02/15/2024 Organon Llc NEXPLANON (Drug) Compensation for serving as faculty or as a speaker for a medical education program Cash or cash equivalent $1,375.00 General
Category: ETONOGESTREL
02/15/2024 Organon Llc NEXPLANON (Drug) Compensation for serving as faculty or as a speaker for a medical education program Cash or cash equivalent $5.23 General
Category: ETONOGESTREL
11/02/2023 Organon LLC NEXPLANON (Drug) Compensation for serving as faculty or as a speaker for a medical education program Cash or cash equivalent $1,375.00 General
Category: ETONOGESTREL
11/02/2023 Organon LLC NEXPLANON (Drug) Compensation for serving as faculty or as a speaker for a medical education program Cash or cash equivalent $5.24 General
Category: ETONOGESTREL
10/23/2023 Organon LLC NEXPLANON (Drug) Compensation for serving as faculty or as a speaker for a medical education program Cash or cash equivalent $1,375.00 General
Category: ETONOGESTREL
10/23/2023 Organon LLC NEXPLANON (Drug) Compensation for serving as faculty or as a speaker for a medical education program Cash or cash equivalent $31.44 General
Category: ETONOGESTREL
10/19/2023 Organon LLC NEXPLANON (Drug) Compensation for serving as faculty or as a speaker for a medical education program Cash or cash equivalent $5.24 General
Category: ETONOGESTREL
09/25/2023 Organon LLC NEXPLANON (Drug) Compensation for serving as faculty or as a speaker for a medical education program Cash or cash equivalent $1,375.00 General
Category: ETONOGESTREL
08/07/2023 Organon LLC NEXPLANON (Drug) Compensation for serving as faculty or as a speaker for a medical education program Cash or cash equivalent $8.19 General
Category: ETONOGESTREL
08/03/2023 Organon LLC NEXPLANON (Drug) Compensation for serving as faculty or as a speaker for a medical education program Cash or cash equivalent $1,375.00 General
Category: ETONOGESTREL
08/03/2023 Organon LLC NEXPLANON (Drug) Compensation for serving as faculty or as a speaker for a medical education program Cash or cash equivalent $1,375.00 General
Category: ETONOGESTREL
07/03/2023 Organon LLC NEXPLANON (Drug) Compensation for serving as faculty or as a speaker for a medical education program Cash or cash equivalent $1,375.00 General
Category: ETONOGESTREL
05/01/2023 Organon LLC NEXPLANON (Drug) Compensation for serving as faculty or as a speaker for a medical education program Cash or cash equivalent $1,375.00 General
Category: ETONOGESTREL
03/17/2023 Organon LLC NEXPLANON (Drug) Compensation for serving as faculty or as a speaker for a medical education program Cash or cash equivalent $43.49 General
Category: ETONOGESTREL
03/16/2023 Organon LLC NEXPLANON (Drug) Compensation for serving as faculty or as a speaker for a medical education program Cash or cash equivalent $1,375.00 General
Category: ETONOGESTREL
03/16/2023 Organon LLC NEXPLANON (Drug) Compensation for serving as faculty or as a speaker for a medical education program Cash or cash equivalent $1,375.00 General
Category: ETONOGESTREL

About Dr. Daniel Rivas, MD

Dr. Daniel Rivas, MD is a Family Medicine healthcare provider based in Burien, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/10/2010. The National Provider Identifier (NPI) number assigned to this provider is 1811209562.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Rivas, MD has received a total of $36,213 in payments from pharmaceutical and medical device companies, with $9,715 received in 2024. These payments were reported across 47 transactions from 2 companies. The most common payment nature is "Compensation for serving as faculty or as a speaker for a medical education program" ($35,072).

Practice Information

  • Specialty Family Medicine
  • Location Burien, WA
  • Active Since 07/10/2010
  • Last Updated 05/07/2024
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • NPI Number 1811209562

Products in Payments

  • NEXPLANON (Drug) $34,797

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Burien